Alkem Laboratories gains 1%; Credit Suisse keeps outperform rating with target of Rs 2275
Shares of Alkem Laboratories added nearly 1 percent as the foreign broking house Credit Suisse has maintained outperform rating on the stock.
The broking house has kept a target of Rs 2275 per share.
The company is offering steady 18-20 percent profit CAGR, it added.
It has reported a 13.63 percent jump in consolidated net profit at Rs 327.44 crore in the quarter ended September 2017 against net profit of Rs 288.15 crore in a year ago period.
The share touched its 52-week high Rs 2,238.00 and 52-week low Rs 1,578.00 on 05 April, 2017 and 11 August, 2017, respectively.
Currently, it is trading 12.42 percent below its 52-week high and 24.21 percent above its 52-week low.
The company’s trailing 12-month (TTM) EPS was at Rs 65.19 per share. (Sep, 2017). The stock’s price-to-earnings (P/E) ratio was 30.07. The latest book value of the company is Rs 367.39 per share.
At 09:42 hrs Alkem Laboratories was quoting at Rs 1,960, up Rs 2.70, or 0.14 percent on the BSE.
Posted by Rakesh Patil